Interestingly, LMNA gene dosage may be also implicated in the pathogenesis of CS, as its overexpression correlates with an elevated level of osteogenic factors including RUNX2 and OCN (Bermeo et al. 2015; Tsukune et al. 2017). Here, LMNA is linked to Cowden syndrome 1.